Workbench for virus designScience DailySamuel Kilcher, a specialist in molecular virology, has played a key role in the breakthrough: he used synthetic biology methods to plan the genome of a bacteriophage on the drawing board and assemble it in a test… Continue reading
2nd man has gene editing; therapy has no safety flags so farFox BusinessThe results might mean it will be harder to develop gene therapies for some neuro-muscular disorders — higher doses in the animal studies were thought necessary to get the therapy … Continue reading
|
2nd man has gene editing; therapy has no safety flags so far
ABC News A second patient has been treated in a historic gene editing study in California, and no major side effects or safety issues have emerged from the first man’s treatment nearly three months ago, doctors revealed Tuesday. Gene editing is a more precise … |
Gizmodo Australia |
DARPA Exec Warns Biohackers To ‘Think Deeply’ About Injecting Untested Treatments
Gizmodo Australia The therapy had gone through no regulatory approval process and had never before tested in humans. It was not the first time such a bold experiment has taken place in the biohacking community. In October, the company behind the herpes stunt sponsored … |
|
Cancer Stem Cell Therapies Market, 2030
GlobeNewswire (press release) The Cancer Stem Cell Therapies Market, 2017-2030′ report examines the current landscape and the future outlook of the growing pipeline of products targeting CSCs. We identified over 150 molecules that are currently being investigated as therapeutic … |
|
Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
Dove Medical Press Abstract: Genetic variations play an important role in the clinical presentation and progression of Alzheimer’s disease (AD), especially early-onset Alzheimer’s disease. Hundreds of mutations have been reported with the majority resulting from … |
Chron.com |
A&M and Celltex partner on stem cell Alzheimer’s research
Chron.com Texas A&M University Health Science Center is partnering with the Houston company that ran into trouble with federal regulators a year after facilitating the 2011 stem–cell treatment of Gov. Rick Perry’s ailing back. Celltex Therapeutics Corp. and A&M … Texas A&M, Celltex Therapeutics to research Alzheimer’s therapies …Houston Business Journal |